5/31/2024 | BKHY | Moody's snips Embecta
|
11/3/2023 | BKHY | Moody’s turns Embecta view to negative
|
8/15/2022 | BKBWHY | Embecta structures balance sheet to fund both organic growth and M&A
|
3/25/2022 | HY | Market Commentary: Yum! below par; junk secondary soft amid Treasury rout; Ford weakens; Owens & Minor holds
|
3/24/2022 | HY | Market Commentary: Yum! doubles; Novolex on deck; Ford at a premium; Owens & Minor gains; funds lose $2.7 billion
|
3/23/2022 | HY | Market Commentary: Junk primary revives; Ford active, Embecta sinks on new offering; Carnival losses mount
|
3/23/2022 | HY | New Issue: Embecta prices $200 million 6¾% eight-year secured notes to yield 7%
|
3/23/2022 | HY | Embecta driving by with $200 million eight-year secured notes; initial talk high-6% area
|
3/23/2022 | BKHY | S&P gives Embecta notes B+
|
1/31/2022 | HY | Market Commentary: Calendar builds; secondary firms; Bausch, Embecta improve; Athena struggles continue
|
1/28/2022 | HY | Market Commentary: ION, Covis on hold; volatile junk market ends day up, week down; athenahealth struggles
|
1/27/2022 | CLHY | Market Commentary: Crocs, Embecta, Intelsat, Bausch Health, TaylorMade, athenahealth, Inspire Brands break
|
1/27/2022 | HY | New Issue: Embecta sells $500 million eight-year secured notes at par to yield 5%
|
1/27/2022 | HY | Embecta talks $500 million eight-year secured notes at 5% area yield; pricing Thursday
|
1/26/2022 | HY | Market Commentary: Trio of junk bonds price; Carnival, Curo lower in volatile secondary; Freeport-McMoRan active
|
1/26/2022 | CLHY | Market Commentary: RelaDyne, AssuredPartners, Alight free to trade; athenahealth revised; Embecta accelerated
|
1/25/2022 | HY | Market Commentary: ION on tap; junk secondary weaker; Oxford outperforms; Medline gains; Netflix active
|
1/24/2022 | BKHY | S&P rates Embecta notes B+
|
1/24/2022 | HY | Embecta starts roadshow for $500 million eight-year secured notes; initial talk high 4% area to 5%
|
1/18/2022 | CLHY | Market Commentary: Griffon tweaks deal; Vaco accelerates deadline; Embecta, Syniverse, Dessert reveal talk
|
1/14/2022 | CLHY | Market Commentary: Micro Focus, Maravai, Simply Good break; Tropicana, Liberty Tire accelerate deadlines
|
1/14/2022 | BKHY | Moody's assigns Embecta, loans Ba3
|
1/14/2022 | BKHY | S&P gives Embecta, loans B+
|